Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Keiichi Masaki"'
Autor:
Masahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, Yuki Inagaki, Kei Morio, Takashi Nakahara, Eisuke Murakami, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Kazuo Awai, Keiichi Masaki, Koji Waki, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya, Yuko Nagaoki, Toru Tamura, Hajime Amano, Yoshio Katamura, Kazuaki Chayama
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background In patients with advanced hepatocellular carcinoma (HCC), evidence is unclear as to whether hepatic arterial infusion chemotherapy (HAIC) or sorafenib is superior. We performed a prospective, open-label, non-comparative phase II s
Externí odkaz:
https://doaj.org/article/b7ffc53bb2d54631a09725a7151575b4
Autor:
Yuko Nagaoki, Michio Imamura, Hiroshi Aikata, Kana Daijo, Yuji Teraoka, Fumi Honda, Yuki Nakamura, Masahiro Hatooka, Reona Morio, Kei Morio, Hiromi Kan, Hatsue Fujino, Tomoki Kobayashi, Keiichi Masaki, Atsushi Ono, Takashi Nakahara, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Yoshiiku Kawakami, C Nelson Hayes, Daiki Miki, Hidenori Ochi, Kazuaki Chayama
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182710 (2017)
The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. However, the risk in patients treated with interferon-free direct-acting antivirals (DAAs) is unknown
Externí odkaz:
https://doaj.org/article/7267274f429042f5bcebbaaceff19f56
Autor:
Wataru Yamasaki, Hideaki Kakizawa, Masaki Ishikawa, Shuji Date, Fuminari Tatsugami, Hiroaki Terada, Keiichi Masaki, Tomokazu Kawaoka, Masataka Tsuge, Hiroshi Aikata, Kazuaki Chayama, Kazuo Awai
Publikováno v:
Acta Radiologica Open, Vol 1, Iss 6, Pp 1-4 (2012)
Transcatheter venous embolization with metallic coils is a safe and reliable method for the treatment of pelvic congestion syndrome and pelvic varicocele. While rare, coil migration to the pulmonary arteries is potentially fatal. We report the migrat
Externí odkaz:
https://doaj.org/article/dca8264c304e4e0b93f0f613cc376d78
Autor:
Yumiko Yamashita, Keiichi Masaki, Takashi Maeda, Nami Mori, Yoshinari Furukawa, Takayuki Fukuhara, Shintaro Takaki, Hideaki Kakizawa, Keiji Tsuji, Nao Kinjou
Publikováno v:
Kanzo. 62:152-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f1d4a54a8cc2d5b031dd8c60e326c80
https://doi.org/10.2957/kanzo.62.152
https://doi.org/10.2957/kanzo.62.152
Autor:
Noriaki Naeshiro, Hiroshi Aikata, Michio Imamura, Takashi Nakahara, Takayuki Fukuhara, Masataka Tsuge, Kazuaki Chayama, Yoji Honda, Keiichi Masaki, Eisuke Murakami, Yuki Yoshikawa, Tomokazu Kawaoka, Keiji Tsuji, Hideyuki Hyogo, Masami Yamauchi, Hatsue Fujino, Nami Mori, Y. Ogawa, Shinsuke Uchikawa, Kensuke Naruto, Akira Hiramatsu, Michihiro Nonaka, Yasuyuki Aisaka, Shoichi Takahashi, Yumi Kosaka, Yuwa Ando, Kei Morio, Takashi Moriya, Kei Amioka, Shintaro Takaki, Chihiro Kikukawa
Publikováno v:
Oncology. 99:507-517
Introduction: We evaluated the efficacy and safety of lenvatinib-transcatheter arterial chemoembolization (LEN-TACE) sequential therapy for patients (n = 88) with intermediate-stage hepatocellular carcinoma (HCC). Methods: Eighty-eight patients who o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f18d1b5657890d41013285338bb52cb
https://doi.org/10.1159/000515865
https://doi.org/10.1159/000515865
Autor:
Masami Yamauchi, Shintaro Takaki, Keiji Tsuji, Yuwa Ando, Y. Ogawa, Masataka Tsuge, Hiroshi Aikata, Michio Imamura, Takayuki Fukuhara, Yoji Honda, Kei Amioka, Kensuke Naruto, Hirotaka Kouno, Yuki Yoshikawa, Hiroshi Kohno, Keiichi Masaki, Chihiro Kikukawa, Kei Morio, Hatsue Fujino, Shinsuke Uchikawa, Takashi Nakahara, Akira Hiramatsu, Kazuaki Chayama, Tomokazu Kawaoka, Eisuke Murakami, Nami Mori, Yumi Kosaka
Publikováno v:
Oncology. 99:327-335
Introduction: The clinical outcome of ramucirumab in multi-molecular targeted agent (MTA) sequential therapy for unresectable hepatocellular carcinoma (u-HCC) was assessed in comparison with that of prior tyrosine kinase inhibitor (TKI) therapy. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c59029b5704a1de02802a415e24d7445
https://doi.org/10.1159/000514315
https://doi.org/10.1159/000514315
Autor:
Keiichi Masaki, Takeshi Mori, Shinichi Mukai, Akira Fukumoto, Naoki Asayama, Youji Honda, Masanobu Yukutake, Shinji Nagata, Taiki Aoyama, Kenjiro Shigita
Publikováno v:
Nihon Naika Gakkai Zasshi. 109:798-803
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be13a9931a4044932152ef1a1fda28b0
https://doi.org/10.2169/naika.109.798
https://doi.org/10.2169/naika.109.798
Autor:
Kei Amioka, Tomokazu Kawaoka, Masanari Kosaka, Yusuke Johira, Yuki Shirane, Ryoichi Miura, Serami Murakami, Shigeki Yano, Kensuke Naruto, Yuwa Ando, Yumi Kosaka, Yasutoshi Fujii, Kenichiro Kodama, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Wataru Okamoto, Masami Yamauchi, Michio Imamura, Nami Mori, Shintaro Takaki, Keiji Tsuji, Keiichi Masaki, Yoji Honda, Hirotaka Kouno, Hiroshi Kohno, Takashi Moriya, Noriaki Naeshiro, Michihiro Nonaka, Hideyuki Hyogo, Yasuyuki Aisaka, Takahiro Azakami, Akira Hiramatsu, Hiroshi Aikata
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 320
Cancers, Vol 14, Iss 320, p 320 (2022)
Cancers
Cancers, Vol 14, Iss 320, p 320 (2022)
Cancers
Simple Summary With the recent increase in the number of drug therapy options for unresectable hepatocellular carcinoma (u-HCC), the key issue has become how to prolong overall survival (OS). The aim was to evaluate the association between radiologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9310f5aa9988956730d59bdf59b2073d
Autor:
Kei Amioka, Tomokazu Kawaoka, Takahiro Kinami, Shintaro Yamasaki, Masanari Kosaka, Yusuke Johira, Shigeki Yano, Kensuke Naruto, Yuwa Ando, Yasutoshi Fujii, Shinsuke Uchikawa, Atsushi Ono, Masami Yamauchi, Michio Imamura, Yumi Kosaka, Kazuki Ohya, Nami Mori, Shintaro Takaki, Keiji Tsuji, Keiichi Masaki, Yoji Honda, Hirotaka Kouno, Hioshi Kohno, Kei Morio, Takashi Moriya, Noriaki Naeshiro, Michihiro Nonaka, Yasuyuki Aisaka, Takahiro Azakami, Akira Hiramatsu, Hiroshi Aikata, Shiro Oka
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5066
Transarterial chemoembolization (TACE) has been the standard treatment for intermediate-stage, unresectable hepatocellular carcinoma (u-HCC). However, with recent advances in systemic therapy and the emergence of the concept of TACE-refractory or -un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61bd796eb62fd395e9c31624a9d9379d
https://doi.org/10.3390/cancers14205066
https://doi.org/10.3390/cancers14205066
Autor:
Takashi Nakahara, Kazuaki Chayama, Tomokazu Kawaoka, Hirotaka Kohno, Kei Amioka, Nami Mori, Hideyuki Hyogo, Keiji Tsuji, Yosuke Suehiro, Y. Ogawa, Michio Imamura, Masami Yamauchi, Takashi Moriya, Noriaki Naeshiro, Michihiro Nonaka, Takayuki Fukuhara, Hatsue Fujino, Yasuyuki Aisaka, Kensuke Naruto, Yoji Honda, Kenichiro Kodama, Masataka Tsuge, Kei Morio, Keiichi Masaki, Eisuke Murakami, Kikukawa Chihiro, Yuwa Ando, Yuki Yoshikawa, Takahiro Azakami, Yumi Kosaka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Hiroshi Kohno, Shintaro Takaki
Publikováno v:
Oncology. 99(8)
Introduction: This study compared clinical outcomes of 2nd- and 3rd-line regorafenib in patients with unresectable hepatocellular carcinoma. Methods: In this retrospective cohort study, 48 patients were treated with regorafenib for unresectable hepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a25da48558a6ef4fcd7b5b2db1858c0
https://pubmed.ncbi.nlm.nih.gov/34000725
https://pubmed.ncbi.nlm.nih.gov/34000725